标题
YB1 Is a Major Contributor to Health Disparities in Triple Negative Breast Cancer
作者
关键词
-
出版物
Cancers
Volume 13, Issue 24, Pages 6262
出版商
MDPI AG
发表日期
2021-12-14
DOI
10.3390/cancers13246262
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Cancer Statistics, 2021
- (2021) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Phosphorylation of the proline-rich domain of WAVE3 drives its oncogenic activity in breast cancer
- (2021) Urna Kansakar et al. Scientific Reports
- A comprehensive review of the functions of YB-1 in cancer stemness, metastasis and drug resistance
- (2021) Akram Alkrekshi et al. CELLULAR SIGNALLING
- Simultaneous Targeting of RSK and AKT Efficiently Inhibits YB-1–Mediated Repair of Ionizing Radiation-Induced DNA Double-Strand Breaks in Breast Cancer Cells
- (2020) Konstanze Lettau et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Blocking Y-Box Binding Protein-1 through Simultaneous Targeting of PI3K and MAPK in Triple Negative Breast Cancers
- (2020) Aadhya Tiwari et al. Cancers
- Racial Disparities in Triple Negative Breast Cancer: A Review of the Role of Biologic and Non-biologic Factors
- (2020) Om Prakash et al. Frontiers in Public Health
- Silencing Y-box binding protein-1 inhibits triple-negative breast cancer cell invasiveness via regulation of MMP1 and beta-catenin expression
- (2019) Jia Pei Lim et al. CANCER LETTERS
- Breast cancer statistics, 2019
- (2019) Carol E. DeSantis et al. CA-A CANCER JOURNAL FOR CLINICIANS
- A novel LncRNA HITT forms a regulatory loop with HIF-1α to modulate angiogenesis and tumor growth
- (2019) Xingwen Wang et al. CELL DEATH AND DIFFERENTIATION
- The WAVE3-YB1 interaction regulates cancer stem cells activity in breast cancer
- (2017) Kamila Bledzka et al. Oncotarget
- Human melanoma cells resistant to MAPK inhibitors can be effectively targeted by inhibition of the p90 ribosomal S6 kinase
- (2017) Corinna Kosnopfel et al. Oncotarget
- Parsing the Etiology of Breast Cancer Disparities
- (2016) Lisa A. Newman JOURNAL OF CLINICAL ONCOLOGY
- Triple negative breast cancer development can be selectively suppressed by sustaining an elevated level of cellular cyclic AMP through simultaneously blocking its efflux and decomposition
- (2016) Wei Wang et al. Oncotarget
- A perfect storm: How tumor biology, genomics, and health care delivery patterns collide to create a racial survival disparity in breast cancer and proposed interventions for change
- (2015) Bobby Daly et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Genome-wide analysis of YB-1-RNA interactions reveals a novel role of YB-1 in miRNA processing in glioblastoma multiforme
- (2015) Shuai-Lai Wu et al. NUCLEIC ACIDS RESEARCH
- Inhibition of RSK with the novel small-molecule inhibitor LJI308 overcomes chemoresistance by eliminating cancer stem cells
- (2015) Alastair H. Davies et al. Oncotarget
- WAVE3-NFκB Interplay Is Essential for the Survival and Invasion of Cancer Cells
- (2014) Gangarao Davuluri et al. PLoS One
- The Cancer Genome Atlas Pan-Cancer analysis project
- (2013) John N Weinstein et al. NATURE GENETICS
- Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
- (2013) J. Gao et al. Science Signaling
- STAR: ultrafast universal RNA-seq aligner
- (2012) Alexander Dobin et al. BIOINFORMATICS
- miR-137 Inhibits the Invasion of Melanoma Cells through Downregulation of Multiple Oncogenic Target Genes
- (2012) Chonglin Luo et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data: Figure 1.
- (2012) Ethan Cerami et al. Cancer Discovery
- Alteration of Y-box binding protein-1 expression modifies the response to endocrine therapy in estrogen receptor-positive breast cancer
- (2011) Tokiko Ito et al. BREAST CANCER RESEARCH AND TREATMENT
- Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
- (2011) Brian D. Lehmann et al. JOURNAL OF CLINICAL INVESTIGATION
- Down-regulation of epithelial cadherin is required to initiate metastatic outgrowth of breast cancer
- (2011) Michael K. Wendt et al. MOLECULAR BIOLOGY OF THE CELL
- Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation
- (2010) Cole Trapnell et al. NATURE BIOTECHNOLOGY
- Triple-negative breast cancer: disease entity or title of convenience?
- (2010) Lisa Carey et al. Nature Reviews Clinical Oncology
- Triple-Negative Breast Cancer
- (2010) William D. Foulkes et al. NEW ENGLAND JOURNAL OF MEDICINE
- The expression of activated Y-box binding protein-1 serine 102 mediates trastuzumab resistance in breast cancer cells by increasing CD44+ cells
- (2010) J Dhillon et al. ONCOGENE
- Transforming growth factor-β-induced epithelial–mesenchymal transition facilitates epidermal growth factor-dependent breast cancer progression
- (2010) M K Wendt et al. ONCOGENE
- Translational Activation of Snail1 and Other Developmentally Regulated Transcription Factors by YB-1 Promotes an Epithelial-Mesenchymal Transition
- (2009) Valentina Evdokimova et al. CANCER CELL
- Biology, Metastatic Patterns, and Treatment of Patients with Triple-Negative Breast Cancer
- (2009) Carey K. Anders et al. Clinical Breast Cancer
- YB-1 prevents apoptosis via the mTOR/STAT3 pathway in HER-2-overexpressing breast cancer cells
- (2009) Teruhiko Fujii et al. Future Oncology
- Racial Disparities in Cancer Survival Among Randomized Clinical Trials Patients of the Southwest Oncology Group
- (2009) Kathy S. Albain et al. JNCI-Journal of the National Cancer Institute
- Targeting YB-1 in HER-2 Overexpressing Breast Cancer Cells Induces Apoptosis via the mTOR/STAT3 Pathway and Suppresses Tumor Growth in Mice
- (2008) Cathy Lee et al. CANCER RESEARCH
- Triple-Negative Breast Cancer: Risk Factors to Potential Targets
- (2008) B. P. Schneider et al. CLINICAL CANCER RESEARCH
- The strand separation and nuclease activities associated with YB-1 are dispensable for cisplatin resistance but overexpression of YB-1 in MCF7 and MDA-MB-231 breast tumor cells generates several chemoresistance signatures
- (2008) David Guay et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Triple Receptor–Negative Breast Cancer: The Effect of Race on Response to Primary Systemic Treatment and Survival Outcomes
- (2008) Shaheenah Dawood et al. JOURNAL OF CLINICAL ONCOLOGY
- RPN2 gene confers docetaxel resistance in breast cancer
- (2008) Kimi Honma et al. NATURE MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started